The Duke and Ivy Methods for Determination of the Bleeding Time

 

^* This investigation was supported by grants from the Swedish Medical Research Council and the National Institutes of Health, Public Health Service (H-4295 R1-C2 and H-07066).

• References

• 1 Björkman S. E. A method for enumeration of the platelets. Acta Haemat 22: 377 1959;
• 2 Blombäck B, Blombäck M. Purification of human and bovine fibrinogen. Arkiv f. Kemi 10: 415-443 1956;
• 3 Borchgrevink C. F. A method for measuring platelet adhesiveness in vivo. Acta med. scand 168: 157-164 1960;
• 4 Borchgrevink C. F. Platelet adhesion in vivo in patients with bleeding disorders. Acta med. scand 170: 231-243 1961;
• 5 Borchgrevink C. F. Platelet adhesion In vivo during secondary bleeding in normal individuals and in patients with clotting defects. Acta med. scand 170: 245-254 1961;
• 6 Borchgrevink C. F. The mechanism of the prolonged bleeding time provoked by dextran sulphate and by excessive doses of heparin. Acta med. scand 170: 365-374 1961;
• 7 BorchgreVink C. F, Owren P. A. The hemostatic effect of normal platelets in hemophilia and factor V deficiency. The importance of clotting factors adsorbed on platelets for normal hemostasis. Acta med. scand 170: 375-383 1961;
• 8 Borchgrevink C. F, Waaler B. A. The secondary bleeding time. A new method for the differentiation of hemorrhagic diseases. Acta med. scand 162: 362-374 1958;
• 9 Duke W. W. The relation of blood platelets to hemorrhagic disease; description of a method for determining the bleeding time and coagulation time and report of three cases of hemorrhagic disease relieved by transfusion. J. Amer. med. Ass 55: 1185 1910;
• 10 Hellem A. J. The adhesiveness of human blood platelets in vitro. Scand. J. clin. Lab. Invest. Suppl. 51 1960
• 11 Hellem A. J, Borchgrevink C. F, Ames S. B. The role of red cells in hemostasis: the relation between haematocrit, bleeding time and platelet adhesiveness. Brit. J. Haemat 07: 42-50 1961;
• 12 Ivy A. C, Shapiro P. F, Melnick P. The bleeding tendency in jaundice. Surg. Gynec. Obstet 60: 781 1935;
• 13 Larrieu M. J. Personal communication.
• 14 Nilsson I. M, Blombäck M, Blombäck B. v. Willebrand’s disease in Sweden. Its pathogenesis and treatment. Acta med. scand 164: 263-278 1959;
• 15 Nilsson I. M, Blombäck M, Francken I. v. On an inherited autosomal hemorrhagic diathesis with antihemophilic globulin (AHG) deficiency ^nd prolonged bleeding time. Acta med. scand 159: 35-57 1957;
• 16 Nilsson I. M, Blombäck M, Francken I. v. On an inherited autosomal haemorrhagic diathesis with antihaemophilic globulin deficiency and prolonged bleeding time. Proceedings of the 6th Congress of the European Society of Haematology, Copenhagen. 1957 02. 629-636 (S. Karger, Basel 1958).
• 17 Nilsson I. M, Blombäck M, Jorpes E, Blombäck B, Johansson S. A. v. Willebrand’s disease and its correction with human plasma fraction I-0. Acta med. scand 159: 179-188 1957;
• 18 Nilsson I. M, Blombäck M, Ramgren O. Haemophilia in Sweden. I. Coagulation Studies. Acta med. scand 170: 665-682 1961;
• 19 Nygaard K. K. A direct method of counting platelets in oxalated plasma. Proc. Mayo Clin 08: 365 1933;
• 20 Quick A. J. The hemorrhagic diseases and the physiology of hemostasis. Charles Thomas; Springfield, Illinois, USA: 305-306 1942